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Abstract
In order to design valid protocols for drug
release via nanocarriers, it is essential to
know the mechanisms of cell internalization,
the interactions with organelles, and the intra-
cellular permanence and degradation of
nanoparticles (NPs) as well as the possible cell
alteration or damage induced. In the present
study, the intracellular fate of liposomes, poly-
meric NPs and mesoporous silica NPs (MSN)
has been investigated in an in vitro cell system
by fluorescence and transmission electron
microscopy. The tested nanocarriers proved to
be characterized by specific interactions with
the cell: liposomes enter the cells probably by
fusion with the plasma membrane and under-
go rapid cytoplasmic degradation; polymeric
NPs are internalized by endocytosis, occur in
the cytoplasm both enclosed in endosomes and
free in the cytosol, and then undergo massive
degradation by lysosome action; MSN are
internalized by both endocytosis and phagocy-
tosis, and persist in the cytoplasm enclosed in
vacuoles. No one of the tested nanocarriers
was found to enter the nucleus. The exposure
to the different nanocarriers did not increase
cell death; only liposomes induced a reduction
of cell population after long incubation times,
probably due to cell overloading. No subcellular
damage was observed to be induced by poly-
meric NPs and MSN, whereas transmission
electron microscopy revealed cytoplasm alter-
ations in liposome-treated cells. This impor-
tant information on the structural and func-
tional relationships between nanocarriers
designed for drug delivery and cultured cells
further proves the crucial role of microscopy
techniques in nanotechnology.
Introduction
Nanomedicine bears nanotechnology and
medicine together, with the aim to obtain new
therapeutic approaches and improve current
treatments.1 The unique features of nanoma-
terials, such as e.g., increased surface area and
quantum effects, are responsible for their
remarkable efficacy in establishing molecular
interactions at the cellular and subcellular
level. Due to these peculiarities, nanocarriers
received special attention in recent years, as
suitable tools for efficiently delivering drugs or
diagnostic agents to the target sites.
Nanoparticles (NPs) may be loaded with rela-
tively large variety of drug molecules (e.g.,
small molecules, peptides, nucleic acids)
which are protected from cleavage by external
agents, and the encapsulated drugs do not par-
ticipate in the control over pharmacokinetic
and biodistribution. Thus, NP-based targeted
therapy has emerged as a unique strategy to
maintain a drug therapeutic dose at the target
site, while reducing systemic drug toxicity and
adverse side effects to healthy tissues.2,3
A plethora of nanosized drug-delivery sys-
tems has been developed, and particular atten-
tion has been paid to liposomes and biodegrad-
able polymeric NPs, as biocompatible and ver-
satile systems to encapsulate active agents.
Liposomes are nanoconstructs made of nat-
ural or synthetic phospholipids surrounding a
water core. Liposomes spontaneously form
when phospholipids are dispersed in water,
and are non-toxic, biodegradable, and biocom-
patible, being phospholipids their major com-
ponent. A wide variety of drugs may be encap-
sulated in liposomes into either the aqueous
core or the surrounding bilayer.4,5 Liposomes,
especially the cationic ones, are also used for
gene therapy, and are considered the most
suitable transfecting vectors among the cur-
rently used synthetic (non-viral) carriers.6-10
Polymeric NPs include nanospheres and
nanocapsules composed of natural or synthetic
polymers, in which drugs can be adsorbed, dis-
solved, entrapped or encapsulated.
Nanospheres are matrix systems where the
loaded drug is uniformly dispersed, while in
nanocapsules the drug is confined to the inner
aqueous or oily cavity surrounded by a tiny
polymeric membrane.11 Polymeric NPs have
good encapsulation efficiency and high stabili-
ty in plasma, and increase the solubility and
stability of hydrophobic drugs while lowering
their toxicity, thus permitting a controlled
release at the target site at relatively low
doses.12-15
Mesoporous silica NPs (MSN) have recently
attracted attention as promising components
of multimodal NP systems, owing to their
straightforward synthesis and functionaliza-
tion, tunable pore size, large drug loading
capacity, good chemical stability, and adequate
biocompatibility.16,17 MSN can encapsulate both
small molecules and oligonucleotides.18
Despite the numerous studies on the physico-
chemical and pharmacological properties of lipo-
somes, polymeric NPs and MSN, little attention
has so far been paid to investigate the mecha-
nisms of cell internalization, organelle interac-
tions, and intracellular permanence and degra-
dation as well as the possible NP-related cell
alteration or damage. This information is essen-
tial for designing suitable protocols for NP-medi-
ated drug delivery,19-21 and in the present study
the intracellular fate of liposomes, polymeric
NPs and MSN has been investigated in an in
vitro cell system by fluorescence and transmis-
sion electron microscopy. 
Materials and MethodsPreparation and characterization of NPs 
Fluorescent labelled liposomes were pre-
pared by thin lipid film hydration and extru-
sion method. Briefly, a chloroform solution of
the lipid components (Avanti Polar-Lipids dis-
tributed by Spectra 2000 Rome, Italy) 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), cholesterol (Chol), and L-a phos-
phatidyl-DL-glycerol sodium salt (PG) (70:30:3
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molar ratios) was evaporated and the resulting
lipid film was dried under vacuum overnight.
Lipid films were hydrated with a 10 mM solu-
tion of fluorescein-5-(and-6)-sulfonic acid
trisodium salt (Invitrogen, Life Technologies,
Monza, Italy) in HEPES [4-(2-hydroxyethyl)
piperazine-1-ethanesulforic acid] buffer (pH
7.4), and the suspension was vortex mixed for
10 min and bath sonicated. The formulations
were extruded (Extruder, Lipex, Vancouver,
Canada) at 60°C passing the suspension 10
times under nitrogen through 220 nm polycar-
bonate membrane (Costar, Corning
Incorporated, NY). To prepare hyaluronated
liposomes, HA17000-DPPE conjugate was previ-
ously prepared as reported by Arpicco et al.4
The lipid films were made up of DPPC/Chol
(70:30 molar ratio) and then hydrated using a
solution of HA17000-DPPE conjugate (3 molar
ratio) in HEPES.
Fluorescent labelled polymeric nanoparti-
cles were prepared by nanoprecipitation of the
copolymer poly(methoxypolyethyleneglycol
cyanoacrylate-co-hexadecyl cyanoacrylate)
(poly(MePEGCA-co-HDCA)) obtained as earli-
er reported22. Practically, 12 mg of the copoly-
mer and 16.8 µg of Nile red ((9-diethylamino-
5H-benzo[a]phenoxazine-5-one), Sigma-
Aldrich, Milan, Italy) were dissolved in 2 mL of
warm acetone; this solution was then added to
4 ml of MilliQ® water under magnetic stirring.
Precipitation of nanoparticles occurred sponta-
neously. After solvent evaporation under
reduced pressure, an aqueous suspension of
fluorescent nanoparticles was obtained.23
Fluorescent liposomes and polymeric NPs were
purified from non-incorporated dye by gel fil-
tration on a Sepharose CL-4B column.
The mean particle size and the polydispersi-
ty index (PI) of liposomes and polymeric
nanoparticles were determined at 25°C by
quasi-elastic light scattering (QELS) using a
nanosizer (Nanosizer Nano Z, Malvern Inst.,
Malvern, UK). The selected angle was 173° and
the measurement was made after dilution of
the nanoparticle suspension in MilliQ® water.
Each measure was performed in triplicate.
Amino-mesoporous silica NPs (NH2-MSN)
were prepared by using cetyltrimethylammoni-
um bromide (CTAB) as structure directing
agent (SDA) as previously described.17
Fluorescein isothiocyanate (FITC) labelled
MSN were prepared as reported by24 with
minor modifications. Briefly, at a suspension
of 1 mg of NH2-MSN in 150 µL of MilliQ® water
250 µL of FITC ethanol solution (0.3 mg/mL)
were added. The mixture was maintained for 5
h under stirring in the dark and then the
nanoparticles were centrifuged and washed
with ethanol three times until the super-
natants were colorless.
The particle surface charge of all formula-
tions was investigated by zeta potential meas-
urements at 25°C applying the Smoluchowski
equation and using the Nanosizer Nano Z.
Measurements were carried out in triplicate.In vitro cell culture
HeLa cells, a human cell line commonly
used for basic research as a standardised in
vitro system, were grown in Dulbecco’s modi-
fied Eagle medium supplemented with 10%
(v/v) fetal calf serum, 1% (w/v) glutamine,
10,000 units/mL of penicillin and 10,000 µg/mL
of streptomycin (Gibco by Life Technologies,
Milan, Italy), at 37°C in a 5% CO2 humidified
atmosphere. Cells were trypsinized (0.25%
trypsin in PBS containing 0.05% EDTA) when
sub-confluent, and seeded either on 12 multi-
well plastic microplates (2¥104 per well) for
cell viability evaluation or glass coverslips in
12-multi-well plastic microplates (1¥104 per
well) for fluorescence and transmission elec-
tron microscopy (TEM). One day after seeding,
the initial medium was replaced with a fresh
one containing fluorescent NP suspensions:
both uncoated and hyaluronic acid-coated lipo-
somes were administered at the concentration
of 500 µg/mL, MSN at 50 µg/mL and polymeric
NPs at 100 µg/ml. The chosen NP concentra-
tions were previously demonstrated to be non-
cytotoxic for various cultured cells.4,14,25 Cells
were incubated with NPs for 2 h, 24 h and 48 h
and then processed as described below; in par-
allel, untreated cells were used as control.
HeLa are highly proliferating cells with a cell
cycle of about 20 h,26 therefore a 48 h incuba-
tion time allows the completion of two cycles.Cell viability assay
To estimate the effect of NPs on cell viabili-
ty, HeLa cultures at all the incubation times
were detached by mild trypsinization and
stained in suspension for 2 min with 0.01%
Trypan blue in the culture medium: cells that
were permeable to Trypan blue were consid-
ered as non-viable and their percentage was
estimated by microscope counting on a Burker
hemocytometer; cell samples not exposed to
NPs were considered as controls. Results were
expressed as the mean ± standard error (SE)
of three independent experiments. 
To evaluate cell growth, 2¥104 cells/well
were seeded on 12 multi-well plastic
microplates and the total cell number was esti-
mated after the different incubation times.
The cells were detached by mild trypsinization
and counted in a Burker hemocytometer, and
the data were expressed as the mean of three
independent experiments ± SE. 
In order to evaluate the effect of NPs
administration on cell proliferation, the S-
phase cells fraction was estimated 2 h, 24 h
and 48 h after NPs exposure: cells grown on
coverslips were pulse-labelled with 20 µM bro-
modeoxyuridine (BrdU, Sigma) for 30 min at
37°C, then fixed with 70% ethanol and treated
for 20 min at room temperature in 2 N HCl, to
denature DNA partially. After neutralization
with 0.1 M sodium tetraborate (pH 8.2) for 3
min, samples were washed in PBS, permeabi-
lized for 15 min in PBS containing 0.1%
bovine serum albumin and 0.05% Tween-20,
and incubated for 1 h with a mouse monoclon-
al antibody recognizing BrdU (BD, Franklin
Lakes, NJ, USA) diluted 1:20 in PBS. After two
washings with PBS, samples were incubated
for 1 h with an Alexafluor 594-conjugated anti-
mouse secondary antibody (Molecular Probes,
Invitrogen, Milan), diluted 1:200 in PBS. The
cell samples were washed with PBS, stained
for 5 min with 1 µg/mL Hoechst 33342
(Sigma) in PBS, and finally mounted in
PBS:glycerol (1:1) to be observed and scored
in fluorescence microscopy (see below). Data
were expressed as the mean of three inde-
pendent experiments ± SE.Analysis of NPs intracellular distri-bution 
At each incubation time, HeLa cells were
fixed for fluorescence microscopy with 4%
(v/v) paraformaldehyde in PBS, pH 7.4, for 30
min at room temperature.
The samples were stained for DNA with
Hoechst 33342 (1 μg/mL in PBS for 5 min;
Sigma), counterstained with 0.1% Trypan blue
in PBS for 30 sec, rinsed in PBS, and mounted
in a 1:1 mixture of glycerol:PBS (Calbiochem,
Inalco, Milan, Italy): this allowed to visualize
the intracellular presence of fluorescent NPs
and to verify their possible intranuclear loca-
tion. An Olympus BX51 microscope equipped
with a 100W mercury lamp (Olympus Italia Srl,
Milan, Italy) was used under the following
conditions: 450-480 nm excitation filter
(excf), 500 nm dichroic mirror (dm), and 515
nm barrier filter (bf), for FITC; 540 nm excf,
580 nm dm, and 620 nm bf, for Nile red; 330–
385 nm excf, 400 nm dm, and 420 nm bf, for
Hoechst 33342. Images were recorded with an
QICAM Fast 1394 digital camera (QImaging,
Surrey, BC, Canada) and processed using
Image-Pro Plus 7.0 software (Media
Cybernetics Inc., Rockville, MD, USA). For
confocal laser scanning microscopy, a Leica
TCS-SP system mounted on a Leica DMIRBE
inverted microscope (Leica Microsystems
Italia, Milan, Italy) was used; for fluorescence
excitation, an Ar/Vis laser at 488 nm for FITC,
a He/Ne laser at 543 nm for Nile red, and an
Ar/UV laser at 364 nm for Hoechst 33258 were
used. Spaced (0.5 µm) optical sections were
recorded using a 63x oil immersion objective.
Images were collected in the 1024¥1024 pixel
format, stored on a magnetic mass memory
and processed by the Leica confocal software.
For TEM, HeLa cells were fixed with 2.5% (v/v)
glutaraldehyde and 2% (v/v) paraformalde-
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hyde in 0.1 M phosphate buffer, pH 7.4, at 4°C
for 2 h, post-fixed with 1% OsO4 and 1.5%
potassium ferrocyanide at room temperature
for 1h, dehydrated with acetone and embed-
ded in Epon. 
Ultrathin sections were weakly stained with
uranyl acetate and observed in a Philips
Morgagni transmission electron microscope
(FEI Company Italia Srl, Milan, Italy) operat-
ing at 80 kV and equipped with a Megaview II
camera for digital image acquisition. 
ResultsCharacterization of NPs
Liposomes (both uncoated and hyaluronic
acid-coated) showed diameters around 230 nm
(uncoated liposomes, 220±6 nm; hyaluronic
acid-coated liposomes, 245±3 nm, PI<0.1). As
previously reported,4 liposome size increases
with the addition of HA-DPPE conjugate. Zeta
potential was negative for both formulations
and was -15.0±0.70 mV for uncoated liposomes
and more negative (-43.0±1.11 mV) for
hyaluronic acid-coated ones due to the pres-
ence of the carboxylic negative residues of HA
on their surface. At TEM, they appeared as
spherical vesicles of low electron density
(Figure 1 a,b).
Polymeric NPs were 104±25 nm in diameter
(PI0.1) and had a zeta potential of -41±0.50
mV; at TEM, they appeared as spherical parti-
cles of moderate electron density (Figure 1c).
MSN were 100±23 nm in diameter with
mesopores of about 3.5 nm, and a zeta poten-
tial of 12.4±0.91 mV. At TEM, MSN appeared as
spherical particles of moderate electron densi-
ty, with well-ordered mesopores (Figure 1d). Cell viability
The Trypan blue exclusion test showed that
the percentage of dead cells in all NP-treated
HeLa samples was lower than 1.5% at all incu-
bation times, at no variance with control sam-
ples (Figure 2a). 
The total number of cells was similar in con-
trol samples and in samples exposed to poly-
meric NPs and MSN at all times considered.
Conversely, cell populations exposed to lipo-
somes underwent significant modification in
comparison to control samples; in detail,
uncoated liposomes induced a decrease after
48 h incubation, while hyaluronic acid-coated
liposomes induced a decrease after both 24 h
and 48 h (Figure 2b). 
The S-phase fraction did not significantly
change after 2 h incubation with all NPs except
from MSN, which showed a significant
increase in BrdU incorporation. After 24 h
incubation, no change was found in all sam-
ples while, after 48 h NPs incubation, BrdU
incorporation significantly decreased in cells
incubated with hyaluronic acid-coated lipo-
somes and polymeric NPs (Figure 2c).Intracellular distribution of NPsLiposomes
Microscopic observations were similar for
uncoated and hyaluronic acid-coated lipo-
somes. Fluorescence microscopy showed that,
after 2 h incubation, several liposomes had
entered HeLa cells; they appeared as isolated
NPs and never accumulated nor formed intra-
cellular aggregates even after 48 h incubation
(Figure 3 a-c). Confocal microscopy confirmed
the limited number of liposomes inside the
cells, and demonstrated that they always local-
ized in the peripheral region of the cell never
entering the nucleus (Figure 4a). At TEM, lipo-
somes were strongly electron dense due to the
lipid staining by osmium tetroxide, and
showed roundish shapes and shaggy profiles
(Figure 5). Many liposomes - both singly and
as small aggregates - were found adhering to
the cell surface, while others occurred inside
the cells, just below the plasma membrane or
in the peripheral region of the cytoplasm
(Figure 5 a,c). No internalization processes
such as endocytosis or phagocytosis were
observed, suggesting a direct translocation
through the cell membrane. Liposomes never
occurred in the inner part of the cytoplasm nor
inside the cell nuclei. After cell internalization,
many liposomes showed a loose filamentous
content, and electron dense fine granular
material occurred nearby in the cytosol (Figure
5b). Moreover, in the cells exposed to lipo-
somes many lipid droplets were found: they
frequently occurred close to the liposomes and
contained the electron dense fine granular
material, which appeared preferentially -
although not exclusively- distributed at their
periphery (Figure 5b). After 2 h, but especially
after 24 h incubation, many lipid droplets accu-
mulated in the outer cytoplasmic region, often
budding from the cell surface until their extru-
sion in the extracellular milieu (Figure 5 c,d).
These lipid droplets were absent in the con-
trols and in the cells treated with the other NP
types. All HeLa cells incubated with liposomes
contained large amounts of vesicular and
membranous structures, although nuclei and
cytoplasmic organelles did not show morpho-
logical alterations. This phenomenon was par-
ticularly evident after 24 h incubation and in
cells treated with hyaluronic acid-coated lipo-
somes. Consistent with the results on cell via-
bility, no necrotic nor apoptotic figures were
ever observed. 
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Figure 1. Transmission electron micrographs of uncoated liposomes (a), hyaluronic acid-
coated liposomes (b), polymeric NPs (c) and MSN (d). Well-ordered mesopores are clear-
ly visible in MSN. a-c). Negative staining. Scale bars: a-c) 100 nm; d) 50 nm.
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Figure 2. Effect of NP treatment on cell proliferation. a) Mean values±SE of dead cell percentage after 2, 24 and 48 h incubation with
the different NPs. b) Mean values±SE of cell number after 2, 24 and 48 h incubation with the different NPs. c) Mean values±SE of
BrdU-positive cell percentage after 2, 24 and 48 h incubation with the NPs. In the histograms, values identified with asterisks are sig-
nificantly different from the control (untreated) cells at the same incubation time. CTR, control; L, liposomes; LHA, hyaluronic acid-
coated liposomes; Poly NPs, polymeric NPs; MSN, mesoporous silica nanoparticles.
Figure 3. Conventional fluores-
cence microscopy analysis of
liposome (green fluorescence, a-
c), polymeric NP (red fluores-
cence, a'-c') and MSN (green flu-
orescence, a''-b'') intracellular
distribution after 2 h (a-a''), 24 h
(b-b'') and 48 h (c-c'') incuba-
tion. All NPs are distributed in
the whole cytoplasm, especially
in the perinuclear region, but are
apparently absent from nuclei.
Polymeric NPs and MSN pro-
gressively accumulate inside the
cells, whereas liposomes do not
show evident accumulation at
increasing treatment times. DNA
is stained with Hoechst 33342
(blue fluorescence); in a-c and
a''-b'' the cytoplasm is counter-
stained with Trypan blue (red
fluorescence). Scale bars: 20 µm.
Polymeric NPs 
Fluorescence microscopy revealed that poly-
meric NPs entered HeLa cells after 2 h incuba-
tion: they appeared as isolated NPs that pro-
gressively increased in number and accumu-
lated in perinuclear areas, after 24 h (Figure 3
a’-c’). Confocal microscopy confirmed their
cytoplasmic distribution and their absence in
the cell nuclei (Figure 4b). At TEM, polymeric
NPs showed a regular round shape and a mod-
erate electron density (Figure 6). Single NPs
were rarely found to adhere to the cell surface
(Figure 6), and in the cytoplasm they appeared
both inside membrane-bounded endosomes
(Figure 6b) and free in the cytosol (Figure 6a);
they never occurred inside the nucleus. After
24 h incubation, a large number of roundish
electron dense residual bodies accumulated in
the perinuclear region of the cytoplasm
(Figure 6e); this phenomenon did not occur in
control cells or in samples treated with MSN or
liposomes. Some polymeric NPs were sur-
rounded by double membranes, as typical of
autophagic figures (Figure 6 c,d). 
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Figure 4. Confocal 500 nm-
spaced optical sections of HeLa
cells after 24 h incubation with
liposomes (green fluorescence,
a), polymeric NPs (red fluores-
cence, b) and MSN (green fluo-
rescence, c). Al the NPs are dis-
tributed in the cytoplasm but are
absent from the nucleus; note the
peripheral location of liposomes.
DNA is stained with Hoechst
33342 (blue fluorescence). In a
and c the cytoplasm is counter-
stained with Trypan blue (red
fluorescence); in b the red fluo-
rescent signal of polymeric NPs
has been merged with the brigh-
field image. Scale bars: 20 µm.
Figure 5. Transmission electron
microscopy analysis of liposomes
intracellular distribution after 2
h (a, b) and 24 h (c, d) incuba-
tion. a) Several liposomes enter
the cell apparently without endo-
cytotic process and occur free in
the cytoplasm. Note their loose
filamentous periphery. b)
Electron dense fine granular
material (arrow) occurs in the
cytosol in close proximity to
liposomes and lipid droplets (L).
Granular material appears dis-
tributed also at the periphery
(arrowheads) of the lipid
droplets (L). c) After 24 h incu-
bation, while liposome uptake
continue (arrow), nearly all lipid
droplets (L) contain electron
dense granular material and
some of them bud from the cell
surface (arrowheads). d) Detail
of a peripheral cellular region:
two lipid droplets (L) containing
granular material approach the
cell surface and one is extruded
(arrowhead). Cell organelles
appear hardly recognizable. Scale
bars: 500 nm.
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No contact between polymeric NPs and cyto-
plasmic organelles, nor indication of cell alter-
ation or damage were ever observed at any
incubation time.MSN 
Observation at conventional and confocal
fluorescence microscopy revealed that, after 
2 h incubation, many MSN were internalized
by HeLa cells, and it was evident that their
amount progressively increased up to 24 h
(Figure 3 a’’-c’’). MSN often occurred as clus-
ters both at the cell surface and inside the
cytoplasm; after 24 h incubation most of MSN
were located around (but never inside) the
nucleus (Figure 4c). At TEM the MSN were
roundish and highly electron dense (Figure
7). According to the observations in fluores-
cence microscopy, many MSN were found to
adhere to the cell surface, frequently as large
aggregates (Figure 7a). Single or few MSN
were internalized by endocytosis (Figure 7c),
while the large clusters entered the cell via
phagocytosis (Figure 7b). In the cytoplasm,
MSN were always found inside vacuoles of var-
ious sizes that were ubiquitously distributed
in the cytoplasm (sometimes very close to the
nuclear envelope), but they were never found
inside cell nuclei (Figure 7 d,e). After 24 h
incubation, MSN were observed inside large
vacuoles (probably secondary lysosomes or
residual bodies) containing heterogeneous
material (Figure 7f). MSN did not contact any
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Figure 6. Transmission electron
microscopy analysis of polymeric
NPs intracellular distribution after
2 h (a-d) and 24 h (e) incubation. a)
Two polymeric NPs occurs at the
cell periphery: one adhering to the
cell surface (arrowhead), the other
freely distributed in the cytosol
(arrow). b) A polymeric NP is
enclosed in an endosome (arrow).
Polymeric NPs are partially (c) and
completely (d) enclosed by
autophagic dual membranes
(arrows). e) After 24 h incubation,
the cytoplasm contains numerous
small and strongly electron dense
residual bodies (arrowheads). G,
glycogen; L, lipid droplet; N, nucleus
Scale bars: 200 nm.
Figure 7. Transmission electron
microscopy analysis of MSN intra-
cellular distribution after 2 h (a-d)
and 24 h (e, f ) incubation. a) Large
aggregates of MSN occurs at the
cell surface (asterisks). Small clus-
ters of MSN are visible inside the
cytoplasm, even inside nuclear
invaginations (arrows). The arrow-
head indicates the detail showed in
b. b) A MSN cluster is internalised
via phagocytosis by the extrusion of
pseudopodia (arrows). c) Small
clusters of MSN enter the cells by
endocytosis (arrows). d-e) Vacuoles
containing MSN (arrows) are ubiq-
uitously distributed in the cyto-
plasm, sometimes very close to the
nucleus (N). f ) MSN occur in large
vacuoles containing heterogeneous
material. L, lipid droplets; N,
nucleus. Scale bars: a) 5 µm; b-f )
500 nm.
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particular organelle, and there was never sign
of subcellular alteration or damage at any
incubation time.
Discussion
Biocompatibility and non-toxicity are essen-
tial prerequisites for nanocarriers to avoid
adverse effects in the patient’s organism, and
are especially important when NPs are aimed
at delivering therapeutic agents to restore the
normal physiological functions in diseased
cells which are to be preserved: this is the case
with highly differentiated non-cycling cells
such as myofibres and neurons. 
In our experimental model, cell death was
apparently unaffected by the exposure to the
various NPs, consistently with previously pub-
lished data by our group4,14 and others.25
However, hyaluronic acid-coated liposomes
were found to significantly reduce cell popula-
tion after both 24 h and 48 h, while uncoated
liposomes induced a decrease after 48 h only.
The slowdown of cell proliferation demonstrat-
ed after 48 h incubation with hyaluronic acid-
coated liposomes partially explains such a cell
number reduction, but it is likely that also cell
death contributes to the population decline.
This is only apparently in contrast with the
results obtained by the Trypan blue exclusion
test; in fact, it should be considered that dead
cells, after detaching from the substrate, may
undergo rapid degradation thus becoming
undetectable: this may cause their underesti-
mation especially at long incubation times. 
Our experimental model seems therefore
more sensitive to the treatment with lipo-
somes in comparison to other previously inves-
tigated cell lines.4 The stronger effect of
hyaluronic-acid-coated liposomes is probably
due to the capability of hyaluronic acid to
increase the uptake efficiency by cells bearing
CD44 receptors24,27 as HeLa cells,28 although
the rapid disaggregation of these NPs does not
allow to observe any difference in their intra-
cellular accumulation. This observation con-
firms and extends previous data demonstrat-
ing that NP biocompatibility may depend -at
least in part- on the cell type.29
Polymeric NPs were found to slow down cell
proliferation after 48 h incubation, although
the total cell number remained unaffected.
This phenomenon has been already observed
in cultured epithelial cells incubated with poly-
meric NPs for 1-3 days30 and may be due to the
intracellular overload of NPs and/or their rem-
nants after long incubation times. The long-
term effect of polymeric NP internalization
certainly deserves further investigation since
a significant reduction in cell proliferation
may represent a predictive sign of cell death.
Conversely, cell proliferation was increased
after brief (2 h) exposure to MSN: this is con-
sistent with previous observations by Christen
et al.31 and our group (unpublished results),
and could be related to the silica-NP-induced
activation of MAPK signaling and the down-
regulation of p53, which in turn inhibit apopto-
sis and induce cell proliferation. 
Fluorescence microscopy demonstrated that
cell uptake is quite rapid and efficient for all
the NPs tested, although evident differences
have been found in their intracellular distribu-
tion. TEM allowed monitoring the fine struc-
tural relationships between NPs and cell com-
ponents, clarifying the uptake mechanisms
and the intracellular fate of internalized NPs.
MSN enter cells in large amounts via both
endocytosis and phagocytosis; once internal-
ized, they always occur inside vacuoles, thus
remaining segregated from the cytosol and
cytoplasmic organelles. MSN were never found
free in the cytosol and this suggests they are
unable to escape endosomes (contrary to other
NP types32-35). MSN do follow the intracellular
lytic pathway, as suggested by the presence of
residual bodies containing numerous NPs and
heterogeneous cellular remnants (this was
especially clear after 24 h incubation). Such an
intracellular behavior must be taken into con-
sideration when using MSN for drug delivery
in vivo: in this case, the therapeutic agents to
be targeted by MSN should be carefully select-
ed to be able to cope with the lytic action of
lysosomal enzymes, and to be capable of pass-
ing through the vacuole membrane before dif-
fusing in the cytoplasm. Interestingly, MSN did
not show any sign of morphological degrada-
tion even inside residual bodies; this demon-
strates their long intracellular persistence and
points to MSN as especially suitable nanovec-
tors for sustained drug release. In addition,
since MSN accumulate very close to the
nuclear envelope, they could profitably be used
to release drugs directed to nuclear targets. It
is worth noting that, despite the large number
of internalized MSN, the cells did not show any
sign of organelle alteration or damage after 24 h
exposure. Consistently, no ultrastructural
alteration was found in a murine myoblast cell
line after 7 days from MSN exposure,36 thus
confirming the good biocompatibility of these
nanovectors. The same study36 demonstrated
that MSN uptake enhances differentiation into
myotubes, opening interesting perspectives for
their use in low renewing differentiated tis-
sues.
Polymeric NPs enter the cell individually
probably via endocytosis, and diffuse in the
whole cytoplasm, accumulating in perinuclear
position after long incubation times. They
occur in the cytoplasm either inside endo-
somes or free in the cytosol, thus suggesting
that these NPs can escape endosomes, as pre-
viously observed for other polymeric NPs.21,33,35
Nevertheless, many polymeric NPs re-enter
the lytic pathway due to the autophagic
process, thus undergoing enzymatic degrada-
tion and giving rise to the numerous residual
bodies observed after 24 h incubation. TEM
observations therefore suggest that many of
the fluorescing spots visible in the cytoplasm
at fluorescence microscopy after long incuba-
tion times might correspond to the remnants
of polymeric NPs inside residual bodies. The
short intracellular permanence of polymeric
NPs suggests that they may be especially suit-
able for rapid drug release. According to previ-
ous observations,37,38 polymeric NPs have never
been found inside cell nuclei.
The uncoated and hyaluronic acid-coated
liposomes show a similar intracellular distri-
bution pattern: they enter massively the cell,
probably mainly by fusion with the plasma
membrane39,40 (although a receptor-mediated
internalization cannot be excluded), and
undergo rapid degradation in the peripheral
region of the cytoplasm (no liposomes have
ever been found in the inner part of the cyto-
plasm or in the nucleus). The presence of
granular electron dense material in close prox-
imity of liposomes and inside the adjacent
lipid droplets suggests that liposome compo-
nents are released and migrate into the cytosol
to accumulate, probably due to chemical affin-
ity, into the lipid deposits. At present, we can-
not establish the reason for liposome degrada-
tion, which could be due to either intracellular
lipases or intrinsic characteristics of the
nanocarriers. In any case, this phenomenon
should be taken into consideration when using
liposomes as drug carriers; in fact, their rapid
degradation could be exploited to allow a rapid
and massive release of the therapeutic agent.
The accumulation and extrusion of lipid
droplets, observed in HeLa cells only after lipo-
some internalization, likely represent different
steps of the compartmentalization and elimi-
nation process of exogenous material due to
excessive NP uptake. Accordingly, signs of
cytological alteration are evident, especially
after internalization of liposomes coated with
hyaluronic acid, which increases uptake effi-
ciency.24,27,28 However, no necrotic or apoptotic
cells were found in the slides incubated with
liposomes, probably due to detachment from
the substrate and/or degradation of dead cells.
It should be underlined that the observation at
fluorescence microscopy did not reveal any sig-
nificant alteration in liposome-treated cells
and only the high resolution of TEM demon-
strated the actual occurrence of subcellular
damages. 
Interestingly, no one of the tested nanocar-
riers was found to enter the nucleus, even
after long incubation times, thus demonstrat-
ing that they are unable not only to pass
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through the nuclear pores but also to be
entrapped by the nuclear envelope when it
reforms after each mitotic cycle.25,41 Entering
cell nuclei might be considered as an advan-
tage for drug-loaded NPs to reach intranuclear
targets; however, it is worth noting that this
may indubitably represent a risk because of
the possible interactions between NPs per se
and nucleic acids and/or nuclear factors, which
could unpredictably alter cell function, irre-
spective of the drug action. In addition, it is
well known that NP-mediated delivery of drugs
or oligonucleotides to nuclear targets does not
require that the nanocarrier enters the nucle-
us,42,43 but essentially depends on the chemical
nature of the therapeutic agents.
The biocompatible nanocarriers designed
for drug delivery that have been tested in this
study are ultimately intended for in vivo
administration and further investigations on
the complex interactions with the whole
organism are mandatory to plan their thera-
peutic utilization. However, a nanocarrier-
based therapeutic strategy cannot disregard
basic knowledge and this study provides essen-
tial information on the structural and function-
al interactions of NPs with the cell compo-
nents, further proving that microscopy tech-
niques (and especially TEM) are irreplaceable
in the attempt to describe the biological behav-
ior of nanovectors.
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